venture.placeOverview
Healthcare

American Industrial Partners to Acquire Avanos Medical in $1.272 Billion Cash Deal

American Industrial Partners (AIP) entered a definitive agreement to acquire Avanos Medical for $25.00 per share in cash. The all-cash transaction is valued at approximately $1.272 billion. The Board of Directors of Avanos unanimously approved the deal. A special meeting of stockholders is scheduled for July 22, 2026, with a record date of June 18, 2026. The acquisition is expected to close in the second half of 2026. The transaction is subject to customary closing conditions, including stockholder approval and regulatory clearances.

124d ago

Market Pulse

Up

0

Down

3

Avg move

0.4%

SEM

2 mentions

0.0%

WHK

1 mentions

-0.1%

ATER

1 mentions

-0.5%

JAZZ

1 mentions

-0.8%

Companies In Focus

Select Medical

SEM · 2 mentions

0.0%

WhiteHawk Income

WHK · 1 mentions

-0.1%

Aterian

ATER · 1 mentions

-0.5%

Jazz Pharmaceuticals

JAZZ · 1 mentions

-0.8%

The Goldman Sachs Group, Inc.

GS · 1 mentions

-0.2%

Sentiment Snapshot

Bullish

2

Neutral

8

Bearish

3

M&A

ARCHIMED to Acquire Esperion Therapeutics for Cash and Contingent Value Rights

ARCHIMED will acquire Esperion Therapeutics for $3.16 per share in cash. Shareholders will also receive one non-tradeable contingent value right. This right allows holders to receive up to $100 million in aggregate milestone payments based on future U.S. product sales. The deal is expected to close in the third quarter of 2026. Closing is subject to regulatory approvals and a shareholder vote. A virtual special meeting for stockholders is scheduled for July 8, 2026.

Reuters
StockTitan
Esperion
126d ago
Healthcare

American Industrial Partners to Acquire Avanos Medical for $1.272 Billion

American Industrial Partners (AIP) affiliates will acquire Avanos Medical for $25.00 per share in an all-cash transaction. This deal values Avanos Medical at approximately $1.272 billion. The acquisition represents a 72.1% premium over Avanos' closing stock price on April 13, 2026. The transaction has received unanimous approval from Avanos' Board of Directors. It is anticipated to close in the second half of 2026. The closing remains subject to customary conditions, including approval from Avanos stockholders and various regulatory clearances, such as the Hart-Scott-Rodino Antitrust Improvements Act.

American Industrial Partners
StockTitan
TradingView
136d ago
Legal Tech

Osborne Clarke Spins Off AI Regulatory Platform Justima

Osborne Clarke launched Justima as an independent AI powered regulatory monitoring platform on May 21, 2026. The startup uses agentic AI to track over 200 legal sources across Europe. It targets corporate legal and compliance teams with automated updates. Osborne Clarke remains the majority shareholder and strategic investor. The platform follows a SaaS subscription model with tiered pricing. It already serves 30 corporate users.

LinkedIn
Justima
Law.com International Edition
Artificial Lawyer
144d ago